There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Harry first visited the African country in 2004 on a gap year.
Mr Erdogan has an “absolute majority”, the country’s national electoral board said.
Footballing success in Russia and a flurry of investigations lead the Monday papers.